SCHEDULE: TD Securities Discloses 6.2% Stake in OneMedNet

TD Securities (USA) LLC has disclosed a 6.2% beneficial ownership stake in OneMedNet Corporation, primarily through exercisable warrants.

Summary

• TD Securities (USA) LLC reported beneficial ownership of 3,025,338 shares of OneMedNet Corporation's Common Stock.
• This beneficial ownership represents 6.2% of the company's outstanding Common Stock.
• The entire stake is comprised of shares issuable upon the exercise of warrants.
• The warrants have an exercise price of $11.50 per share and are currently exercisable.
• The percentage of class calculation is based on 49,120,985 shares of Common Stock deemed outstanding as of June 30, 2025, plus the warrants.
• The reporting persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The disclosure of a significant stake by a reputable financial institution is generally a positive signal, suggesting institutional interest. However, the stake is passive and entirely through warrants, which introduces a degree of contingency and potential future dilution.

Positives

• A significant financial institution, TD Securities (USA) LLC, holds a substantial stake, potentially indicating institutional confidence in OneMedNet Corporation.
• The warrants are presently exercisable, offering flexibility to the holder to convert them into common stock.

Negatives

• The beneficial ownership is entirely through warrants, meaning the shares are not yet fully owned and their exercise is contingent on the warrant holder's decision and market conditions relative to the $11.50 exercise price.

Risks

• The exercise of warrants could lead to dilution for existing shareholders if the warrant holder decides to convert them into common stock, increasing the total number of outstanding shares.
• The value of the warrants is subject to the market price of OneMedNet Corporation's common stock relative to the $11.50 exercise price, introducing market risk.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing indicates a significant passive investment by a major financial institution in OneMedNet Corporation, which is a common occurrence in financial markets where institutions take positions in companies for investment purposes without seeking control or strategic influence.

Stakeholder Impact

• Shareholders: Potential dilution if warrants are exercised, increasing the number of outstanding shares. The presence of a significant institutional investor might be viewed positively as a vote of confidence.
• Company (OneMedNet Corporation): Potential capital infusion if warrants are exercised, providing funds for operations or growth initiatives.

Key Dates

Recommendation

The filing indicates a significant, passive institutional investment via warrants. While the presence of a major financial institution as a beneficial owner can be a positive signal, the investment is not a direct equity purchase and the exercise of warrants is contingent on market conditions relative to the $11.50 strike price. This disclosure alone does not provide sufficient operational or financial performance data to warrant a 'buy' or 'sell' recommendation, suggesting a 'hold' position until further fundamental analysis is possible.

Keywords

OneMedNet Corporation, TD Securities, Schedule 13G, Beneficial Ownership, Warrants, Common Stock, SEC Filing, Institutional Ownership, Equity Stake